Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.500
0.00 (0.00%)
May 13, 2026, 4:00 PM EDT - Market closed
Camp4 Therapeutics Employees
Camp4 Therapeutics had 48 employees as of December 31, 2025. The number of employees decreased by 7 or -12.73% compared to the previous year.
Employees
48
Change (1Y)
-7
Growth (1Y)
-12.73%
Revenue / Employee
$81,958
Profits / Employee
-$1,797,938
Market Cap
233.67M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 48 | -7 | -12.73% |
| Dec 31, 2024 | 55 | -9 | -14.06% |
| Sep 30, 2024 | 53 | -11 | -17.19% |
| Jun 30, 2024 | 58 | - | - |
| Dec 31, 2023 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| Orchestra BioMed Holdings | 86 |
| Keros Therapeutics | 78 |
| Milestone Pharmaceuticals | 38 |
| Fennec Pharmaceuticals | 35 |
| NovaBridge Biosciences | 30 |
CAMP News
- 6 days ago - Camp4 Therapeutics reports Q1 EPS (32c), consensus (21c) - TheFly
- 6 days ago - CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire
- 15 days ago - CAMP4 Therapeutics Preprints Pioneering Study on Regulatory RNA Profiling and Gene Upregulation - GlobeNewsWire
- 26 days ago - CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Camp4 Therapeutics initiated with a Buy at Rodman & Renshaw - TheFly
- 4 weeks ago - Camp4 Therapeutics Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 5 weeks ago - Camp4 Therapeutics price target raised to $9 from $8 at Leerink - TheFly
- 7 weeks ago - CAMP4 Appoints Michael MacLean to its Board of Directors - GlobeNewsWire